This document mainly introduces the status quo and treatment methods of epilepsy.
This two-page press release, dated 13 July 2020, was issued by the press department of the Sociedad Española de Neurología (SEN). It announces that the SEN Epilepsy Study Group (GESEN), coordinated by Dr. Francisco Javier López, has published a new Manual de Práctica Clínica en Epilepsia (Clinical Practice Manual in Epilepsy) intended to help healthcare professionals with decision-making in specific clinical situations.
The release cites figures from the SEN: epilepsy affects around 400,000 people in Spain with 20,000 new cases diagnosed each year, and in Europe it affects about six million people at a sociosanitary cost of 20 billion euros per year. It notes that diagnostic delay can reach 10 years and that about one third of patients remain drug-resistant. The manual is divided into 5 chapters covering diagnostic, classificatory, therapeutic and prognostic aspects, management of the epileptic patient from pharmacology to surgery, and ends with a formulary of antiepileptic drugs. A download link to the manual is included. This manual is written in Spanish.
According to data from the SEN, epilepsy affects around 400,000 people in Spain and 20,000 new cases are diagnosed each year.
The manual is divided into 5 chapters, covering diagnostic and therapeutic aspects, management of the epileptic patient, prognosis, and a formulary of antiepileptic drugs.
Despite advances in treatments, around one third of patients remain pharmacoresistant.
The press release states that epilepsy has a good prognosis in most cases, and with good control and treatment response remission is achieved in up to 84% of cases.